BackProteomics International Laboratories Overview
Proteomics International Laboratories Ltd.

Proteomics International Laboratories Return on Equity

Proteomics International Laboratories (PIQ.AX) has a ROE of -287.17%, below the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

-287.17%

Return on Equity

-287.17%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Proteomics International Laboratories (PIQ.AX) FAQ

The latest ROE for PIQ.AX is -287.17%. That is below the sector sector average of 11.3%. Investors often review this figure alongside Proteomics International Laboratories's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, PIQ.AX currently prints -287.17% for ROE, while the sector average sits near 11.3%. That is roughly 2642.1% below the sector mean. Large gaps often invite a closer look at Proteomics International Laboratories's growth, margins, and balance sheet.

Return on Equity shows how effectively Proteomics International Laboratories converts resources into returns. At -287.17%, PIQ.AX may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PIQ.AX's ROE (-287.17%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.